Asia-Pacific Blood Collection Market Research Report Forecast to 2030
The growth of the APAC blood collection market is attributed to the high prevalence of anemia and other blood disorders, the growing number of accidents & trauma cases, and the rising demand for diagnostic procedures. However, the injury caused during blood collection and stringent government policies are attributed to retarding market growth. Nonetheless, it is anticipated that the growing government initiatives are creating lucrative opportunities for the APAC blood collection market.
The expected growth in the APAC blood collection market can be attributed to the high prevalence of anemia and other blood disorders, and growing number of accidents & trauma cases, and rising demand for diagnostic procedures. However, the market is also held back by injury caused during blood collection and stringent government policies. Nevertheless, it is anticipated that the growing government initiatives will create lucrative opportunities for the players operating in the APAC blood collection market.
Market SegmentationBased on the application, the Asia-Pacific blood collection market has been segmented into diagnostics and treatments. The diagnostics segment dominated the market in 2022 and is projected to be the fastest–growing segment during the forecast period, 2023–2030.
The Asia-Pacific blood collection market, based on method, has been segmented into manual blood collection and automated blood collection. Based on the end user, the Asia-Pacific blood collection market has been segmented into diagnostic & pathology laboratories, hospitals & clinics, blood banks and others. The Asia-Pacific blood collection market consists of India, Japan, Singapore, Malaysia, South Korea, Australia & New Zealand, and Rest of Asia-Pacific.
Major PlayersFresenius Kabi AG (Germany) Medtronic Plc (Ireland), Becton, Dickinson, and Company (US), Quest Diagnostics Incorporated (US), Grifols S.A. (Spain), Kawasumi Laboratories America (US), Nipro Medical Corporation (Japan), Terumo Medical Corporation (Japan), ICU Medical, Inc (US), Haemonetics Corporation (US).
Companies MentionedFresenius Kabi AG (Germany) Medtronic Plc (Ireland)
Becton
Dickinson
and Company (US)
Quest Diagnostics Incorporated (US)
Grifols S.A. (Spain)
Kawasumi Laboratories America (US)
Nipro Medical Corporation (Japan)
Terumo Medical Corporation (Japan)
ICU Medical
Inc (US)
Haemonetics Corporation (US).
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.